ANNOUNCEMENT

Join us at MedCity CONVERGE July 9-10 in Philadelphia, and hear from ALL healthcare innovation sectors.

Device maker for minimally invasive GI procedures raises $3M, turns to GERD, obesity

Device maker for minimally invasive GI procedures raises $3M, turns to GERD, obesity

April 2, 2013 10:16 am by | 0 Comments

Investors have backed a company making disposable devices for minimally invasive gastroenterology procedures with a new $3 million in capital, according to a U.S. Securities and Exchange Commission filing.SafeStitch Medical’s ... Read more

Colonoscopy tied to lower risk of advanced cancer

Colonoscopy tied to lower risk of advanced cancer

March 4, 2013 5:07 pm by | 0 Comments

NEW YORK (Reuters Health) - People who have had a colonoscopy in the past decade are less likely to be diagnosed with advanced colon cancer than those who haven't been ... Read more



Diabetes drugs tied to pancreatitis: study

Diabetes drugs tied to pancreatitis: study

February 28, 2013 4:05 pm by | 1 Comments

NEW YORK (Reuters Health) - People who take a certain type of diabetes drug to lower blood sugar levels may be at an increased risk of developing an inflamed pancreas, ... Read more


Pig whipworms might be latest icky treatment for gut conditions

Pig whipworms might be latest icky treatment for gut conditions

February 21, 2013 6:14 am by | 0 Comments

Mollie Heinz had two surgeries to remove parts of her bowel due to flareups of Crohn's disease.Even so, the 37-year-old mother from Maryland Heights isn't so hot about the idea ... Read more

Avaxia cleared to start human trials of oral antibody for Crohn’s disease, ulcerative colitis

Avaxia cleared to start human trials of oral antibody for Crohn’s disease, ulcerative colitis

November 28, 2012 3:53 pm by | 0 Comments

A 7-year-old pharmaceutical company that’s developed a new way to create and deliver an old kind of drug is making the critical transition to the clinical stage as it prepares ... Read more

Bayer’s regorafenib for gastrointestinal tumors gets priority review by FDA

Bayer’s regorafenib for gastrointestinal tumors gets priority review by FDA

October 29, 2012 12:25 pm by | 0 Comments

FRANKFURT (Reuters) - U.S. health regulators granted a priority review for Bayer's cancer drug regorafenib for the treatment of gastrointestinal stromal tumors, potentially speeding up the treatment's route to market.The ... Read more

Drug combo for ulcerative colitis looks to phase 2 trial, partnership

Drug combo for ulcerative colitis looks to phase 2 trial, partnership

March 12, 2012 1:41 pm by | 0 Comments

A promising new combination drug for ulcerative colitis treatment is looking for investments to carry it through a phase 2 efficacy trial this year.Altheus Therapeutics Inc.’s candidate, Zoenasa, combines the ... Read more


New IBS drug: Salix will make case for approval at June meeting with FDA

New IBS drug: Salix will make case for approval at June meeting with FDA

May 5, 2011 7:55 pm by | 0 Comments

Salix Pharmaceuticals (NASDAQ:SLXP) believes that there’s enough solid data available now to warrant U.S. Food and Drug Administration approval of its new irritable bowel syndrome drug and at a meeting ... Read more

Salix expands drug delivery technology partnership with Indian pharma

Salix expands drug delivery technology partnership with Indian pharma

April 6, 2011 1:26 pm by | 0 Comments

Salix Pharmaceuticals is extending an agreement with an Indian pharmaceutical partner to give Salix exclusive global rights, except for India, to a key drug-delivery technology.Morrisville, North Carolina-based Salix (NASDAQ:SLXP) in ... Read more

Drug approval now unlikely for Salix bowel treatment

Drug approval now unlikely for Salix bowel treatment

February 24, 2011 11:07 am by | 1 Comments

The U. S. Food and Drug Administration has signaled it will not approve an irritable bowel syndrome treatment being developed by Morrisville, North Carolina-based Salix Pharmaceuticals. Salix says it won't ... Read more

NinePoint Medical, Mass. General Hospital ink patent licensing deal

NinePoint Medical, Mass. General Hospital ink patent licensing deal

December 13, 2010 12:30 pm by | 0 Comments

NinePoint Medical Inc. signs a licensing deal with Mass. General Hospital for 188 of the institution’s patents and patent applications.NinePoint Medical Inc. entered into a licensing deal with Mass. General ... Read more

Older lady makes it through bowel surgery. I’ll take it

Older lady makes it through bowel surgery. I’ll take it

September 1, 2010 9:42 am by | 0 Comments

The life of a general surgeon is one fraught with contingency, soul-crushing doubt, unexpected disaster, and overwhelming stress. We wade into shark infested waters every time we press scalpel into ... Read more

Torax Medical gets European OK for acid reflux disease device

Torax Medical gets European OK for acid reflux disease device

April 7, 2010 11:10 am by | 0 Comments

Torax Medical Inc. has received regulatory approval from the European Union to sell an implantable device that treats patients suffering from acid reflux disease.The company’s Linx device is intended for ... Read more

For MAX Endoscopy, $250,000 investment from JumpStart means ‘fresh breath’ for the new year

For MAX Endoscopy, $250,000 investment from JumpStart means ‘fresh breath’ for the new year

December 30, 2009 3:08 pm by | 1 Comments

MAX Endoscopy Inc. in Macedonia, Ohio, has received a $250,000 investment commitment from JumpStart Inc., the venture development organization in Cleveland. MAX Endoscopy will use the money to formalize sales ... Read more

The dying art of physical exam

The dying art of physical exam

April 28, 2009 8:52 am by | 0 Comments

The Buckeye Surgeon writes about an exam in which he felt an "obvious large, soft, mobile mass in the left lower quadrant." Four others had seen it. He gets a ... Read more